Drug
D0452 | aurovertin B
| Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| ELECTRON TRANSPORT CHAIN | 1.5 μM | bovine | heart mitochondria | Measurement of complex V activity | decrease | IC50 | 3 | |
| Target | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| ATP synthase | 1.5 μM | bovine | heart mitochondria | Measurement of complex V activity | inhibitor | IC50 | 3 | |
| (1S)-4-O-acetyl-1,5:3,6-dianhydro-7,8-dideoxy-1-[(1E,3E,5E)-6-(4-methoxy-5-methyl-2-oxo-2H-pyran-6-yl)hexa-1,3,5-trien-1-yl]-3,5-dimethyl-D-glycero-L-talo-octitol | AUR | DB07394 |
| Q27096613 | SCHEMBL21067566 | aurovertin b |
| DrugBank Name | AUROVERTIN B |
| DrugBank | DB07394 |
| CAS Number | 55350-03-3 |
| PubChem Compound | 6441012 |
| Wikipedia | Ауровертин |